Europe Brain Cancer Diagnostics Market Developments and Forecast by 2028

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028

Europe Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, and Others); Cancer Type (Acoustic Neuroma, Astrocytoma, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, and Others); End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Report Date : Nov 2021
Report Code : TIPRE00025898

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 161

Page Updated: Nov 2021

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The brain cancer diagnostics market in Europe is expected to grow from US$ 207.5 million in 2021 to US$ 601.0 million by 2028; it is estimated to grow at a CAGR of 16.4% from 2021 to 2028.

Currently, there is insufficient evidence that they are less harmful than traditional cigarettes. Researchers at Wake Forest School of Medicine have discovered that nicotine promotes the spread of lung cancer cells to the brain, thereby forming deadly metastatic tumors. The study, published in the Journal of Experimental Medicine (JEM), suggests that nicotine replacement therapy may not be suitable for lung cancer patients trying to quit smoking. Thus, the increase in the number of cigarette smokers is bolstering the growth of the brain cancer diagnostics market.

Patients with cancer have been negatively impacted during the COVID-19 pandemic, as many of these individuals may be immunosuppressed and of older age. Additionally, cancer follow-up or imaging appointments have been delayed in many clinics around the world. Postponement of routine screening examinations will result in delays in new cancer diagnoses. Clinics are continuing to monitor and adapt their appointment schedules based on local outbreaks of COVID-19. Studies on COVID-19 in patients with cancer are limited, but consistently indicate that this population is at risk for more severe COVID-19 illness. Data from recent studies also suggest that pediatric patients with cancer have a lower risk of severe COVID-19 illness compared with adults. Certain features of SARS-CoV-2 infection detected by lung, brain, and gastrointestinal imaging may confound radiologists’ interpretation of cancer diagnosis, staging, and treatment response. Lastly, as clinics begin to reopen for routine appointments, protocols have been put in place to reduce SARS-CoV-2 exposure to patients during their visits. This review details different perspectives on the impact of the COVID-19 pandemic on patients with cancer and on cancer imaging.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the brain cancer diagnostics market. The Europe brain cancer diagnostics market is expected to grow at a good CAGR during the forecast period.

Europe brain cancer diagnostics market

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Europe Brain Cancer Diagnostics Market Segmentation

By Diagnostic Type

Imaging Test
- MRI
- CT Scan
- PET
Biopsy
Molecular Testing
Lumbar Puncture
Others

By Cancer Type

Glioblastoma Multiforme
Astrocytomas
Ependymomas
Others

By End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others

By Country

Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe

Companies Mentioned

Thermo Fisher Scientific Inc.
Siemens Healthineers A
GE Healthcare
Biocept, Inc.
Koninklijke Philips N.V
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems

Europe Brain Cancer Diagnostics Report Scope

Report Attribute	Details
Market size in 2021	US$ 207.5 Million
Market Size by 2028	US$ 601.0 Million
Global CAGR (2021 - 2028)	16.4%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Diagnostic Type Imaging Test Lumbar Puncture Biopsy Molecular Testing By Cancer Type Acoustic Neuroma Astrocytoma Craniopharyngiomas Ganglioneuromas Glioblastoma Multiforme Meningiomas Ependymomas By End User Hospitals Specialty Clinics Ambulatory Surgical Centers
Regions and Countries Covered	Europe UK Germany France Russia Italy Rest of Europe
Market leaders and key company profiles	Thermo Fisher Scientific Inc. Siemens Healthineers A GE Healthcare Biocept, Inc. Koninklijke Philips N.V Canon Medical Systems Hitachi, Ltd. Neusoft Medical Systems

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Europe Brain Cancer Diagnostics Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy